advanced radiation treatment planning of prostate cancer
Authors
abstract
0
similar resources
Radiation treatment planning for prostate cancer: A new dosimetric comparison of five and seven fields IMRT plans
Background: To compare the dosimetric coverage of the planning target volume (PTV) and the dose delivered to the main Organs at Risk (OARs) in 5 and 7-field techniques of Intensity Modulated Radiation Therapy (IMRT) in patients with local prostate cancer. Materials and Methods: Twelve patients with local prostate cancer underwent 5 and 7-field IMRT planning. The delivery of IMRT was carried out...
full textAnalysis of Hip Joint Dose in Prostate Cancer Radiation Therapy: A Dosimetric Comparison of Treatment Plans
Background and purpose: Radiation therapy as a part of cancer treatment is used in almost 50-60% of involved cases. In prostate cancer radiation therapy, a large volume of pelvis is irradiated, so, it is necessary to preserve sensitive organs around the treatment area, especially rectum and bladder. In this study, some dosimetric parameters such as minimum dose (Dmin), maximum dose (Dmax), mean...
full textProstate cancer: 9. Treatment of advanced disease.
A 70-year-old man is referred to a urologist for recommendations on the management of metastatic prostate cancer. His cancer was diagnosed 5 years ago, and he underwent radical prostatectomy at that time. The tumour was confined to the prostate gland (Gleason score 7), and during surgery the lymph nodes were assessed as being clear of cancer. Before the surgery, the patient's prostate-specific ...
full textTreatment strategies for locally advanced prostate cancer.
With the increasing aged population, prostate cancer has become one of the commonest malignant tumors in the United States. The incidence of prostate cancer is the highest among malignant tumors in males, and the mortality rate is the second highest following lung cancer. Even when prostate cancer is diagnosed to be in the early stage preoperatively, its excised lesions are often judged pathohi...
full textDegarelix for the treatment of advanced prostate cancer compared with GnRh-Agonists: a systematic review and meta-analysis
Background: Hormone therapy is currently the mainstay in the management of locally advanced and metastatic prostate cancer. We performed a systematic review to compare safety, efficacy and effectiveness of degarelix, a new gonadotropin-releasing hormone (GnRH) antagonist (blocker), versus gonadotropin-releasing hormone (GnRH) agonists. Methods: MEDLINE, Web of Science and the Cochrane librar...
full textXWH - 12 - 1 - 0477 TITLE : Reducing toxicity of radiation treatment of advanced prostate cancer
Bone marrow suppression due to ionizing radiation is a significant clinical problem in radiation therapy andfollowing non-medical radiation exposure. Currently, no small molecule agents that can enhance hematopoieticregeneration following radiation exposure are available. Here, we report the effective mitigation of acutehematopoietic radiation syndrome in mice by the synthetic trite...
full textMy Resources
Save resource for easier access later
Journal title:
middle east journal of cancerجلد ۶، شماره ۳، صفحات ۱۹۹-۰
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023